Keyphrases
Small Molecules
100%
PAC1 Receptor
100%
Antidepressants
100%
Receptor Antagonist
57%
Major Depressive Disorder
57%
Psychiatric Disorders
28%
Monoamine Hypothesis
28%
Mouse Model
14%
Etiology
14%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
14%
Promising Target
14%
Safety Profile
14%
High Affinity
14%
Brain-inspired
14%
Monoamines
14%
Treatment-resistant Depression
14%
Acute Stress
14%
Nonapeptides
14%
High Safety
14%
Impact on Society
14%
Stress Disorders
14%
Behavioral Pharmacology
14%
Newer Antidepressants
14%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Receptor Antagonist
100%
Antidepressant
100%
Major Depression
100%
Monoamine
75%
Disease
25%
Mouse Model
25%
Hypophysis Adenylate Cyclase Activating Polypeptide
25%
Treatment Resistant Depression
25%
Behavioral Pharmacology
25%
Neuroscience
Receptor Antagonist
100%
Major Depressive Disorder
100%
Antidepressant
100%
Receptor
100%
Monoamine
75%
Hypophysis Adenylate Cyclase Activating Polypeptide
25%
Treatment-Resistant Depression
25%
Behavioral Pharmacology
25%